Pfizer dumps midphase NASH prospect, slew of early efforts in ...https://www.fiercebiotech.com › biotech › pfizer-dump...
Jul 28, 2021 — Pfizer has removed a nonalcoholic steatohepatitis (NASH) liver disease prospect from its pipeline after wrapping up a phase 2 clinical trial ...